Qiagen Patents – Key Insights and Stats

Qiagen has a total of 4641 patents globally, out of which 2379 have been granted. Of these 4641 patents, more than 40% patents are active. The United States of America is where Qiagen has filed the maximum number of patents, followed by Europe and Germany. Parallelly, Germany seems to be the main focused R&D centre and also is the origin country of Qiagen.

Qiagen was founded in 1984 by Metin Colpan. Qiagen provides sample and assay technologies. The Company offers such technologies for molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, as well as applied testing customers for purposes such as forensics, animal and food testing, and pharmaceutical process control. As of October 2022, Qiagen has a market cap of $9.56 Billion.

Do read about some of the most popular patents of Qiagen which have been covered by us in this article and also you can find Qiagen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Qiagen patent portfolio.

How many patents do the Founder and CEO of Qiagen have?

The Founder Metin Colpan has 116 patents, and the CEO Thierry Bernard has 205 patents.

How many patents does Qiagen have?

Qiagen has a total of 4641 patents globally. These patents belong to 1182 unique patent families. Out of 4643 patents, 1883 patents are active.

How Many Patents did Qiagen File Every Year?

Qiagen Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantQiagen Applications FiledQiagen Patents Granted
201130493
2012277146
2013280147
2014160157
2015182187
2016240173
2017100189
201877184
2019106149
202087135
202137103
20221355

How many Qiagen patents are Alive/Dead?

Worldwide Patents

Qiagen Patents Portfolio

How Many Patents did Qiagen File in Different Countries?

Qiagen Worldwide Patents

Countries in which Qiagen Filed Patents

CountryPatents
United States Of America930
Europe789
Germany537
Japan420
Australia281
China261
Canada164
Austria111
Spain98
Korea (South)56
Denmark55
United Kingdom55
India53
Singapore44
Brazil41
Hong Kong (S.A.R.)26
Israel22
Russia20
Portugal16
Taiwan14
South Africa14
Mexico12
Norway11
Turkey9
Poland8
Hungary8
Slovenia5
New Zealand4
Lithuania3
Cyprus3
Slovakia2
Czech Republic2
Switzerland2
France1
Chile1
Iceland1
Eurasia1
Indonesia1

Where are Research Centers of Qiagen Patents Located?

Research Centers of Qiagen Patents

10 Best Qiagen Patents

US6670461B1 is the most popular patent in the Qiagen portfolio. It has received 1806 citations so far from companies like Isis Pharmaceuticals, Sankyo Company, and Amgen.

Below is the list of 10 most cited patents of Qiagen:

Publication NumberCitation Count
US6670461B11806
US6794499B21704
US7034133B21256
US6770748B21159
US6339068B11030
US6828100B1751
US7084125B2708
US7572582B2431
US7060809B2423
US20040219565A1320

Which Companies are using Qiagen Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Qiagen patent portfolio are Life Technologies, Roche Molecular Systems and Becton Dickinson.

List of the top forward citing Companies –

CompanyNumber of Patents
Life Technologies20
Roche Molecular Systems12
Becton Dickinson10
U.S. Department of Health and Human Services10
Applied Bio systems Llc10
Bio-Rad Laboratories9
Samsung Electronics8
Ibis Biosciences Inc7
Global Life Sciences Solutions7
Ionis Pharmaceuticals7

Count of 102 and 103 Type Rejections based on Qiagen Patents

Top Qiagen Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20060176167A118
US6870165B215
US8192937B212
US6617137B210
US20080117029A110
US8932542B29
US20060105372A19
US20100086990A18
US6864100B17
US6361940B17
US10458998B27
US20040219565A17
US20050053942A17
US20030152927A16
US7060809B26

What Percentage of Qiagen US Patent Applications were Granted?

Qiagen (Excluding its subsidiaries) has filed 419 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 261 have been granted leading to a grant rate of 66.41%.

Below are the key stats of Qiagen patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Qiagen?

Law FirmTotal ApplicationsSuccess Rate
Seed IP8266.67%
Fanelli Haag6960.87%
Mcbee Moore & Vanik6570.77%
Ballard Spahr5960.34%
Rankin Hill & Clark2455.00%
Leon R Yankwich1957.89%
Sterne Kessler Goldstein & Fox11100.00%
Seyfarth Shaw977.78%
Mcdonnell Boehnen Hulbert & Berghoff8100.00%
Clark & Elbing7100.00%

What are Qiagen key innovation segments?

What Technologies are Covered by Qiagen?

The chart below distributes patents filed by Qiagen in different countries on the basis of the technology protected in patents. It also represents the markets where Qiagen thinks it’s important to protect particular technology inventions.

R&D Focus: How has Qiagen search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Qiagen?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.